Switch View
© Globe Newswire
25.08.2025
ISIN: US07373V1052
Beam Therapeutics Inc
BEAM
LISTED
NASDAQ
Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences
News Preview
Beam Therapeutics Inc. (Nasdaq: BEAM) management will be participating in several healthcare investor conferences in September...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
New Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma
News Preview
Castle announced the publication of two new studies related to its DecisionDx-SCC test for patients with high-risk cutaneous squamous cell carcinoma....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
News Preview
– 3-year data from open-label extension (OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on top of standard anti-seizure medicines –...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
25.08.2025
ISIN: US8294011080
Sionna Therapeutics Inc
SION
LISTED
NASDAQ
Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis
News Preview
Dosing initiated for SION-451 combined with SION-2222 and SION-451 combined with SION-109 in healthy volunteers; topline data anticipated in mid-2026 Dosing initiated for SION-451 combined with SION-2222 and SION-451 combined with SION-109 in healthy volunteers; topline data anticipated in mid-2026...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
25.08.2025
ISIN: US0080642061
Jade Biosciences Inc
JBIO
LISTED
NASDAQ
Jade Biosciences to Participate in Upcoming Conferences
News Preview
Jade Biosciences to Participate in Upcoming Conferences...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
ISIN: US05463X1063
AxoGen Inc
AXGN
LISTED
NASDAQ
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
News Preview
FDA PDUFA goal date extended by three months FDA PDUFA goal date extended by three months...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
News Preview
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a royalty interest in Amgen’s Imdelltra, a first-in-class DLL3 targeting bispecific T-cell engager (BiTE), from BeOne Medicines for $885 million upfront. The agreement includes an option for BeOne to sell additional Imdelltra royalti...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.08.2025
ISIN: US0050831009
Actuate Therapeutics, Inc.
ACTU
LISTED
NASDAQ
Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy
News Preview
Phase 2 study showed a doubling of the survival rate of metastatic pancreatic cancer patients at Year 1, an unprecedented outcomeTechnology is seen as transformative in increasing the effectiveness of treatment for a wide range of cancers CHICAGO, IL AND FORT WORTH, TX / ACCESS Newswire / August 25, 2025 / Vexing challenges await cancer researchers...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: DK0061804697
H Lundbeck A/S
HLUN A
LISTED
CPH
Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy
News Preview
The full results of the open label extension (OLE) of the Phase 1b/2a PACIFIC trial investigating bexicaserin for the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs), will be presented for the first time at the International Epilepsy Annual Congress1DEEs are the most severe rare epilepsies, characterized by drug-res...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: DK0061804697
H Lundbeck A/S
HLUN A
LISTED
CPH
Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy
News Preview
The full results of the open label extension (OLE) of the Phase 1b/2a PACIFIC trial investigating bexicaserin for the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs), will be presented for the first time at the International Epilepsy Annual Congress1DEEs are the most severe rare epilepsies, characterized by drug-res...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Leqembi® (lecanemab) launched in the EU today
News Preview
STOCKHOLM, Aug. 25, 2025 /PRNewswire/ --BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025. Leqembi received the European Commission (EC) approval in April 2025 as the first therapy that targ...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.08.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
$12.9M Dual Logoman Auto Sale Highlights MDCE (OTC PINK:MDCE) Subsidiary Infinite Auctions' Move Into Tom Brady 1/1 NFL Logo Auto
News Preview
Acquisition underscores Infinite Auctions' momentum as 1-of-1 cards of sports legends reach record-breaking values MESA, ARIZONA / ACCESS Newswire / August 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its subsidiary, Infinite Auctions, has successfully acquired a Tom Brady 2009 Topps Unique Game-Worn NFL Logo Shiel...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
25.08.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Leqembi® (lecanemab) launched in the EU today
News Preview
STOCKHOLM, Aug. 25, 2025 /PRNewswire/ --BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025. Leqembi received the European Commission (EC) approval in April 2025 as the first therapy that targ...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: DK0061804697
H Lundbeck A/S
HLUN A
LISTED
CPH
Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy
News Preview
The full results of the open label extension (OLE) of the Phase 1b/2a PACIFIC trial investigating bexicaserin for the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs), will be presented for the first time at the International Epilepsy Annual Congress1DEEs are the most severe rare epilepsies, characterized by drug-res...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
TLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with the Schall Law Firm
News Preview
LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ: TLX) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT
News Preview
LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws.
Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class P...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder b...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS
News Preview
LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.08.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma Expands CALMA Phase 2 Trial with Site at Lynn Health Science Institute in Oklahoma City
News Preview
POTOMAC, MD / ACCESS Newswire / August 25, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced the expansion of its ongoing Phase 2 clinical trial evaluating IGC-AD1, an investigational drug candidate for treating agitation in patients with Alzheimer's disease. The Company has added a clinical site at the Lynn Health Science Institute (LHSI...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints
News Preview
HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) ("Akeso" or "the Company") today announced positive results from its Phase 3 clinical trial of gumokimab (AK111), a novel, fully human anti-IL-17A monoclonal antibody, for the treatment of active ankylosing spondylitis (AS). The study successfully met all primary efficacy endpoints, in...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.08.2025
ISIN: US74366E1029
Protagonist Therapeutics Inc
PTGX
LISTED
NASDAQ
Rusfertide Receives Breakthrough Therapy Designation for Treatment of Erythrocytosis in Patients with Polycythemia Vera
News Preview
Breakthrough Therapy designation complements Rusfertide's Orphan Drug and Fast Track designations, which together confer multiple benefits to the development programU.S. New Drug Application filing for Rusfertide in polycythemia vera on track for Q4 NEWARK, CA / ACCESS Newswire / August 25, 2025 / Protagonist Therapeutics, Inc. ("Protagonist&q...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)
News Preview
TOKYO and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the anti-amyloid beta (Aβ) monoclonal antibody “LEQEMBI®” has been launched i...
Themefolio
Profiler
Peergroup
© EQS Newswire
25.08.2025
ISIN: CH0039821084
Metall Zug AG
METN
LISTED
SIX
Metall Zug – result for the first half of 2025
News Preview
Ad hoc announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange
Zug, August 25, 2025 – Metall Zug (SIX: METN) announces result for the first half of 2025
Haag-Streit launches three new, innovative products – a world novelty is being introduced in its core core business of slit lamps
Change of CEO at Haag-Streit: Thomas Lenzen will tak......
Themefolio
Profiler
Peergroup
© EQS Newswire
25.08.2025
ISIN: CH0039821084
Metall Zug AG
METN
LISTED
SIX
Metall Zug – Ergebnis für das erste Halbjahr 2025
News Preview
Ad hoc-Mitteilung gemäss Art. 53 Kotierungsreglement
Zug, 25. August 2025 – Metall Zug (SIX: METN) veröffentlicht das Ergebnis für das erste Halbjahr 2025
Haag-Streit führt drei neue, innovative Produkte auf dem Markt ein – im Kerngeschäft Spaltlampen wird eine Weltneuheit lanciert
CEO-Wechsel bei Haag-Streit: Thomas Lenzen übernimmt die CEO-Rolle......
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting
News Preview
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General MeetingNew Board Structure Reflects Balanced and Proportionate Shareholder Representation New Governance to Drive Strategic Roadmaps for Tedopi® and Lusvertikimab...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: KYG4403H1002
Hbm Holdings Limited
2142
LISTED
HKSE
Harbour BioMed Appoints Yajie Li as Chief Medical Officer
News Preview
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 24, 2025 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the appointment of Yajie Li as Chief Medical Officer (CMO). Ms. Li...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: KYG4818G1010
Innovent Biologics Inc
1801
LISTED
HKSE
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer
News Preview
SAN FRANCISCO and SUZHOU, China, Aug. 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing and commercializing high-quality medicines in oncology, cardiovascular and metabolic diseases, autoimmune, ophthalmology and other major therapeutic area...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
ISIN: KYG4672N1198
HUTCHMED (China) Ltd
13
LISTED
HKSE
HUTCHMED Announces Appointment of Acting Chief Executive Officer
News Preview
HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that Dr Weiguo Su, an Executive Director of the Company, will take a leave of absence from his duties as Chief Executive Officer due to health reasons. In light of this, the Board of Dir...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or faile...
Themefolio
Profiler
Peergroup
© BusinessWire
24.08.2025
ISIN: US81728J1097
Sensus Healthcare, Inc.
SRTS
LISTED
NASDAQ
SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sensus Healthcare, Inc. (“Sensus” or “the Company”) (NASDAQ: SRTS) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed...
Themefolio
Profiler
Peergroup
© PR Newswire
23.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
HIMS Deadline: HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates in...
Themefolio
Profiler
Peergroup
© PR Newswire
23.08.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates in...
Themefolio
Profiler
Peergroup
© PR Newswire
23.08.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
NEOGEN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Neogen Corporation - NEOG
News Preview
NEW ORLEANS, Aug. 22, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 16, 2025 to file lead plaintiff applications in a securities class action lawsuit against Neogen Corporation (NasdaqGS: NEOG), if they purchased the Company's shares between January 5, 2023 through June...
Themefolio
Profiler
Peergroup
© PR Newswire
23.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investor News: Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation - LFMD
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from alleg...
Themefolio
Profiler
Peergroup
© Newsfile
23.08.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence Therapeutics Announces Debenture Units Financing
News Preview
Montreal, Quebec--(Newsfile Corp. - August 22, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce a non-brokered private placement of debenture units (the "Units") at a price of $1,000 per Unit for aggr...
Themefolio
Profiler
Peergroup
© PR Newswire
23.08.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclus...
Themefolio
Profiler
Peergroup
© BusinessWire
22.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
HIMS & HERS HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company’...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
News Preview
NEW ORLEANS, Aug. 22, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities betwe...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto's initial public offering conducted on or about February 2, 2024 (the "IPO"); and/or (ii) securities between February 2, 2024 and October 22, 2...
Themefolio
Profiler
Peergroup
© BusinessWire
22.08.2025
ISIN: US60783X1046
ModivCare, Inc.
MODVQ
LISTED
OTC
Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing
News Preview
Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, announced that, on August 21, 2025, the Company was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: CA45783P1027
Innocan Pharma Corporation
INNO
LISTED
CSE
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada
News Preview
PAINWeek is the premier US conference in pain management Innocan's Poster "Is Long-Acting Synthetic Cannabidiol a Solution to Chronic Pain?" to be highlighted HERZLIYA, Israel and CALGARY, AB, Aug. 22, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutic...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: CA45783P1027
Innocan Pharma Corporation
INNO
LISTED
CSE
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada
News Preview
PAINWeek is the premier US conference in pain management Innocan's Poster "Is Long-Acting Synthetic Cannabidiol a Solution to Chronic Pain?" to be highlighted HERZLIYA, Israel and CALGARY, AB, Aug. 22, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2025
ISIN: CA03835T3091
Aptose Biosciences Inc.
APTO
LISTED
NASDAQ
Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor
News Preview
Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
BHVN Deadline: BHVN Investors with Losses in Excess of $100K Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the "Class Period"), of the important September 12, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
SRPT Deadline: SRPT Investors with Losses in Excess of $100K Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates incl...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2025
ISIN: US58510H1032
MEDIROM Healthcare Technologies Inc.
MRM
LISTED
NASDAQ
MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World"
News Preview
Acquires ETH as part of financial strategy Acquires ETH as part of financial strategy...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.08.2025
ISIN: CA0909741062
BioNxt Solutions Inc.
BNXT
LISTED
CSE
Promotional Activity Engagements
News Preview
VANCOUVER, BC / ACCESS Newswire / August 22, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) reports two investor relations engagements.The Company has engaged Apaton Finance GmbH ("Apaton"), wholly owned by Mario Hose, of Ellernstr. 34, 30175 Hannover, Germany (email: office@apa...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
INVESTOR DEADLINE MONDAY: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SRPT
News Preview
SAN DIEGO, Aug. 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), have until this Monday, August 25, 2025 to seek appointment as lead plaintiff of the Sarepta class act...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
News Preview
WARREN, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), announced today that it has been named in BINJE’s BEST Health Care 2025: Companies, Organizations and Service Providers. BINJE, a media outlet covering business and politics across New Jersey, highlighted Tevogen Bio’s Founder an...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release22 August 2025 WORLDWIDE HEALTHCARE TRUST PLC(the "Company") MARKET PURCHASE OF COMPANY'S OWN SHARES This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 9 July 2025 to make market purchases of the Company's own shares up to an aggregate maximum of 69,602,221. T...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: CA74449Q1063
Psyence Group Inc
PSYG
LISTED
CSE
Canadian Investment Regulatory Organization Trade Resumption - PSYG
News Preview
VANCOUVER, BC, Aug. 22, 2025 /CNW/ - Trading resumes in:
Company: Psyence Group Inc
CSE Symbol: PSYG
All Issues: Yes
Resumption (ET): 12:00 PM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the natio...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wil...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Capricor between October 9, 2024 and July 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Biohaven To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Biohaven between March 24, 2023 and May 14, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 21 August 2025 was 354.28p (cum income). ...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US74006W2070
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ("Praxis" or the "Company") (NASDAQ: PRAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
ISIN: US37733W2044
GSK plc
GSK
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK
News Preview
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE: GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
